Rachel K. Hopper

2.9k citations

42 papers · 1.6k indexed · h-index 20

Pulmonary and Respiratory Medicine top 2%
Surgery top 10%
Molecular Biology
Epidemiology top 10%
Cardiology and Cardiovascular Medicine top 5%

Co-authors: Jeffrey A. Feinstein Steven H. Abman Lingli Wang Aiqin Cao Marlene Rabinovitch Erika B. Rosenzweig D. Dunbar Ivy Isabel Diebold
Topics: Pulmonary Hypertension Research and Treatments (25 papers)Congenital Heart Disease Studies (17 papers)Neonatal Respiratory Health Research (12 papers)
Cited by: Pulmonary and Respiratory Medicine Cardiology and Cardiovascular Medicine Epidemiology
Journals: Circulation Biochemistry American Journal of Respiratory and Critical Care Medicine
Partner nations: United States Canada Austria

In The Last Decade

Rachel K. Hopper

39 papers receiving 1.6k citations

Peers

Countries citing papers authored by Rachel K. Hopper

Since Specialization

Citations

This map shows the geographic impact of Rachel K. Hopper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel K. Hopper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel K. Hopper more than expected).

Fields of papers citing papers by Rachel K. Hopper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel K. Hopper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel K. Hopper. The network helps show where Rachel K. Hopper may publish in the future.

Co-authorship network of co-authors of Rachel K. Hopper

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel K. Hopper. A scholar is included among the top collaborators of Rachel K. Hopper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel K. Hopper. Rachel K. Hopper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical Management and Transplant Considerations in Pediatric Pulmonary Hypertension Due to Left Heart Disease: A Scientific Statement From the American Heart Association 2024 ·Circulation Heart Failure ·Rachel K. Hopper,Georg Hansmann,Seth A. Hollander,Anne I. Dipchand,(unknown),(unknown),Cynthia Herrington,Erika B. Rosenzweig,Juan Alejos,Karin Tran‐Lundmark	1
2	Younger age at initiation of subcutaneous treprostinil is associated with better response in pediatric Group 1 pulmonary arterial hypertension 2024 ·Pulmonary Circulation ·(unknown),Jeffrey A. Feinstein,(unknown),(unknown),Rachel K. Hopper,(unknown)	1
3	Cardiac Catheterization and Hemodynamics in a Multicenter Cohort of Children with Pulmonary Hypertension 2022 ·Annals of the American Thoracic Society ·Erika B. Rosenzweig,(unknown),Mary P. Mullen,Steven H. Abman,Eric D. Austin,Allen D. Everett,Jeffrey R. Fineman,Jeffrey A. Feinstein,Rachel K. Hopper,John P. Kinsella,Usha Krishnan,Minmin Lü,Kenneth D. Mandl,J. Usha Raj,Nidhy P. Varghese,Delphine Yung,Stephanie S. Handler,Lynn A. Sleeper	13
4	Role of left atrial hypertension in pulmonary hypertension associated with bronchopulmonary dysplasia 2022 ·Frontiers in Pediatrics ·(unknown),(unknown),Shazia Bhombal,(unknown),Derek Boothroyd,Michael C. Tracy,Amanda J Moy,Rachel K. Hopper	7
5	Subcutaneous Treprostinil Improves Surgical Candidacy for Next Stage Palliation in Single Ventricle Patients With High-Risk Hemodynamics 2022 ·Seminars in Thoracic and Cardiovascular Surgery ·(unknown),Stephanie S. Handler,Jeffrey A. Feinstein,(unknown),Esther Liu,Michael Ma,Rachel K. Hopper,(unknown),Seth A. Hollander,Sharon Chen	3
6	Pulmonary Hypertension in Children with Down Syndrome: Results from the Pediatric Pulmonary Hypertension Network Registry 2022 ·The Journal of Pediatrics ·Rachel K. Hopper,Steven H. Abman,(unknown),Catherine M. Avitabile,Delphine Yung,Mary P. Mullen,Eric D. Austin,(unknown),Stephanie S. Handler,Jeffrey A. Feinstein,D. Dunbar Ivy,John P. Kinsella,Kenneth D. Mandl,J. Usha Raj,Lynn A. Sleeper	10
7	Characterisation of paediatric pulmonary hypertensive vascular disease from the PPHNet Registry 2021 ·European Respiratory Journal ·Steven H. Abman,Mary P. Mullen,Lynn A. Sleeper,Eric D. Austin,Erika B. Rosenzweig,John P. Kinsella,D. Dunbar Ivy,Rachel K. Hopper,J. Usha Raj,Jeffrey R. Fineman,Roberta L. Keller,(unknown),Usha Krishnan,Catherine M. Avitabile,Alexander Davidson,Marc D. Natter,Kenneth D. Mandl	52
8	Pulmonary Arterial Hypertension: Diagnosis, Treatment, and Novel Advances 2021 ·American Journal of Respiratory and Critical Care Medicine ·Bradley A. Maron,Steven H. Abman,C. Gregory Elliott,Robert P. Frantz,Rachel K. Hopper,Evelyn M. Horn,Mark R. Nicolls,Oksana A. Shlobin,Sanjiv J. Shah,Gábor Kovács,Horst Olschewski,Erika B. Rosenzweig	111
9	Pharmacokinetics of Oral Treprostinil in Children With Pulmonary Arterial Hypertension 2020 ·Journal of Cardiovascular Pharmacology ·Rachel K. Hopper,D. Dunbar Ivy,Delphine Yung,Mary P. Mullen,Brian D. Hanna,(unknown),Russel Hirsch,Eric D. Austin,Jeffrey R. Fineman,Derek Solum,C. Q. Deng,Jeffrey A. Feinstein	3
10	Patent Ductus Arteriosus and the Effects of Its Late Closure in Preterm Infants with Severe Bronchopulmonary Dysplasia 2019 ·Neonatology ·(unknown),Haresh Kirpalani,Laura Mercer‐Rosa,Yan Wang,Rachel K. Hopper,María V. Fraga,Erik A. Jensen	6
11	Racial and Ethnic Differences in Pediatric Pulmonary Hypertension: An Analysis of the Pediatric Pulmonary Hypertension Network Registry 2019 ·The Journal of Pediatrics ·Mei‐Sing Ong,Steve Abman,Eric D. Austin,Jeffrey A. Feinstein,Rachel K. Hopper,Usha Krishnan,Mary P. Mullen,Marc D. Natter,J. Usha Raj,Erika B. Rosenzweig,Kenneth D. Mandl	18
12	Death or resolution: the “natural history” of pulmonary hypertension in bronchopulmonary dysplasia 2019 ·Journal of Perinatology ·Gabriel Altit,Shazia Bhombal,Rachel K. Hopper,Theresa A. Tacy,Jeffrey A. Feinstein	46
13	The Left Ventricle in Congenital Diaphragmatic Hernia: Implications for the Management of Pulmonary Hypertension 2018 ·The Journal of Pediatrics ·John P. Kinsella,Robin H. Steinhorn,Mary P. Mullen,Rachel K. Hopper,Roberta L. Keller,D. Dunbar Ivy,Eric D. Austin,Usha Krishnan,Erika B. Rosenzweig,Jeffrey R. Fineman,Allen D. Everett,Brian D. Hanna,Tilman Humpl,J. Usha Raj,Steven H. Abman	91
14	Pulmonary Vein Stenosis: Outcomes in Children With Congenital Heart Disease and Prematurity 2018 ·Seminars in Thoracic and Cardiovascular Surgery ·Michael P. DiLorenzo,(unknown),Jonathan J. Rome,Huayan Zhang,Jennifer Faerber,Laura Mercer‐Rosa,Rachel K. Hopper	28
15	Use of prostaglandin E1 to treat pulmonary hypertension in congenital diaphragmatic hernia 2018 ·Journal of Pediatric Surgery ·Kendall M. Lawrence,(unknown),Lisa M. Herkert,(unknown),(unknown),(unknown),Emily A. Partridge,Brian D. Hanna,William H. Peranteau,Catherine M. Avitabile,Rachel K. Hopper,Natalie E. Rintoul,Holly L. Hedrick	34
16	Treprostinil Improves Persistent Pulmonary Hypertension Associated with Congenital Diaphragmatic Hernia 2018 ·The Journal of Pediatrics ·Kendall M. Lawrence,Holly L. Hedrick,Heather M. Monk,Lisa M. Herkert,(unknown),Brian D. Hanna,William H. Peranteau,Natalie E. Rintoul,Rachel K. Hopper	41
17	Evaluation and Management of Pulmonary Hypertension in Children with Bronchopulmonary Dysplasia 2017 ·The Journal of Pediatrics ·Usha Krishnan,Jeffrey A. Feinstein,Ian Adatia,Eric D. Austin,Mary P. Mullen,Rachel K. Hopper,Brian D. Hanna,(unknown),Roberta L. Keller,Jeffrey R. Fineman,Robin H. Steinhorn,John P. Kinsella,D. Dunbar Ivy,Erika B. Rosenzweig,Usha Raj,Tilman Humpl,Steven H. Abman,John D. Coulson,(unknown),(unknown)	160
18	Persistent Challenges in Pediatric Pulmonary Hypertension 2016 ·CHEST Journal ·Rachel K. Hopper,Steven H. Abman,D. Dunbar Ivy	23
19	Neonatal pulmonary arterial hypertension and Noonan syndrome: Two fatal cases with a specific RAF1 mutation 2015 ·American Journal of Medical Genetics Part A ·Rachel K. Hopper,Jeffrey A. Feinstein,Melanie A. Manning,W.E. Benitz,Louanne Hudgins	16
20	BMPR2 Preserves Mitochondrial Function and DNA during Reoxygenation to Promote Endothelial Cell Survival and Reverse Pulmonary Hypertension 2015 ·Cell Metabolism ·Isabel Diebold,Jan K. Hennigs,Kazuya Miyagawa,Caiyun G. Li,Nils Nickel,Mark Kaschwich,Aiqin Cao,Lingli Wang,Sushma Reddy,Pin-I Chen,Kiichi Nakahira,Miguel A. Alejandre Alcázar,Rachel K. Hopper,Lijuan Ji,Brian J. Feldman,Marlene Rabinovitch	176

About Rachel K. Hopper

Rachel K. Hopper is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Epidemiology, having authored 42 papers that have together received 1.6k indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (25 papers), Congenital Heart Disease Studies (17 papers) and Neonatal Respiratory Health Research (12 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.1k citations), Cardiology and Cardiovascular Medicine (311 citations) and Epidemiology (420 citations). Rachel K. Hopper has collaborated with scholars based in United States, Canada and Austria. Frequent co-authors include Jeffrey A. Feinstein, Steven H. Abman, Lingli Wang, Aiqin Cao, Marlene Rabinovitch, Erika B. Rosenzweig, D. Dunbar Ivy, Isabel Diebold, Jan K. Hennigs and Stephanie French. Their work appears in journals such as Circulation, Biochemistry and American Journal of Respiratory and Critical Care Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact